Advanced Medical Solutions, and SJE Group investment, has acquired French company Biomatlante; a well-established international developer and manufacturer of innovative surgical biomaterial technologies.
Biomatlante’s biosurgical products, which are sold mainly in Europe, are complementary to AMS’s surgical product portfolio and generated sales of more than €4 million in 2018. AMS anticipates increasing the sales of these products in other jurisdictions through its existing global commercial infrastructure, as well as leveraging Biomatlante’s established presence in France for the Group’s existing surgical product portfolio.
The R&D pipeline and platform technologies which AMS acquired will broaden the Group’s biosurgical technology offering while also offering multiple synergies across the sales, marketing, regulatory, operational divisions and R&D.
The SJE Group congratulates Chris Meredith (CEO of AMS), Chantal Gobin-Daculis (Co-founder and President of Biomatlante) and their respective teams.